The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world treatment outcomes in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who were treated with first-line single-agent ibrutinib vs. chemoimmunotherapy.
 
Ruibin Wang
Employment - Janssen Scientific Affairs
Stock and Other Ownership Interests - Janssen Scientific Affairs
 
Zhijie Ding
Employment - Janssen Scientific Affairs
Stock and Other Ownership Interests - Janssen Scientific Affairs
 
Xiaoxiao Lu
Employment - Janssen Scientific Affairs
Stock and Other Ownership Interests - Janssen Scientific Affairs
 
Heena Mavani
Employment - Janssen Scientific Affairs
Stock and Other Ownership Interests - Janssen Scientific Affairs
 
Jinghua He
Employment - Janssen Scientific Affairs
Stock and Other Ownership Interests - Janssen Scientific Affairs
 
Zaina P. Qureshi
Employment - Janssen Scientific Affairs
Stock and Other Ownership Interests - Janssen Scientific Affairs
 
Javier Pinilla-Ibarz
Honoraria - Abbvie; AstraZeneca; Janssen; Novartis; Pharmacyclics; Takeda
Consulting or Advisory Role - Abbvie; Janssen; Novartis; Pharmacyclics
Speakers' Bureau - Abbvie; AstraZeneca; Pharmacyclics/Janssen; Takeda
Patents, Royalties, Other Intellectual Property - From a WT vaccine patent by Memorial Sloan Kettering Cancer Center